Skip to content

Therapeutic Effects of a New Upper Limb Robot Assisted Therapy Device for Persons After Stroke

Active Smart Wearable Orthosis Using Painted EMG Electrodes for Home Based Therapy With Augmentative Feedback

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01723046
Acronym
ARTHE
Enrollment
10
Registered
2012-11-07
Start date
2013-02-28
Completion date
2014-09-30
Last updated
2012-12-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Upper extremity, Rehabilitation, Robot assisted therapy, Robotics, Devices, Orthosis, clinical outcome

Brief summary

The purpose of this pilot study is to investigate the clinical effects of a new upper limb robot assisted therapy device that is linked to a virtual therapy environment in patients with stroke.

Detailed description

The number of physically weak individuals is increasing, resulting in a higher burden on health care and health care workers. The use of robot assisted therapy (RAT) might partly solve this problem. Rehabilitation progress highly depends on training intensity and training duration, favouring the use of RAT. In this pilot study, the clinical effects of using a new upper arm RAT device for upper arm rehabilitation in patients with stroke is investigated. Myo-electrical signals will serve as input for the device, assisting the user in flexion and extension of the elbow. The device is coupled to a virtual environments, creating a stimulating therapy environment.

Interventions

During 8 weeks, 3 times a week, 1 hour therapy sessions with the device

Sponsors

Thomas More Kempen
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patients with stroke, more than three months post onset * No or moderate spasticity in the upper limb (maximum score of 3 on Modified Ashworth Scale) * Observable voluntary muscle activity in biceps and triceps muscle of the affected upper limb (minimal score of 1 on the Medical research council score) * Able to sit on a chair with adequate trunk stability * Able to follow verbal instructions * Able to communicate verbal information to the researchers

Exclusion criteria

* Patients who are medically unstable * Cognitive disorders impeding the intervention * Visual disorders impeding the intervention * Subluxation of the shoulder joint * Pusher syndrome

Design outcomes

Primary

MeasureTime frameDescription
Modified Ashworth ScaleChange from baseline Modified Ashworth Scale at 8 weeks and 12 weeksSpasticity measurement
Fugl-Meyer test upper limb sectionChange from baseline Fugl-Meyer test upper limb section at 8 weeks and 12 weeksStroke specific, performance based impairment index. Applied to determine disease severity and describe motor recovery.
Medical research council scoreChange from baseline Medical research council score at 8 weeks and 12 weeksMuscle strength assessment
Active range of motion of the elbow jointChange from baseline active range of motion of the elbow joint at 8 weeks and 12 weeksThe maximum range of motion to flexion and extension of the elbow joint that the person can achieve independently
Passive range of motion of the elbow jointChange from baseline passive range of motion of the elbow joint at 8 weeks and 12 weeksThe maximum range of motion to flexion and extension of the elbow joint of the test person that can be achieved by the assessor.

Secondary

MeasureTime frameDescription
Functional independence measureChange from baseline Functional independence measure score at 8 weeks and 12 weeksAssessment of physical and cognitive disability, focusing on the burden of care.
Stroke impact scaleChange from baseline Stroke impact scale score at 8 weeks and 12 weeksQuestionnaire evaluating how stroke has impacted the person's health and life.
Intrinsic motivation inventoryChange from baseline Intrinsic motivation inventory score at 8 weeks and 12 weeksMultidimensional measurement device intended to assess participants' subjective experience related to a target activity in laboratory experiments.
ABILHAND questionnaireChange from baseline ABILHAND questionnaire score at 8 weeks and 12 weeksQuestionnaire-based assessment of manual ability

Countries

Belgium

Contacts

Primary ContactLore Van de Perre, MSc
lore.van.de.perre@khk.be+32 14 56 23 10

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026